|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.7 EUR | 0.00% |
|
+0.15% | +99.12% |
| Apr. 11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
| Apr. 11 | Trending : Novartis Begins Tender Offer for MorphoSys Shares | DJ |
MorphoSys AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was EUR 278.27 million compared to EUR 179.61 million a year ago. Net loss was EUR 151.06 million compared to EUR 514.46 million a year ago.
Basic loss per share from continuing operations was EUR 4.42 compared to EUR 15.4 a year ago. Diluted loss per share from continuing operations was EUR 4.42 compared to EUR 15.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +99.12% | 2.72B | |
| -1.42% | 41.35B | |
| +42.15% | 40.38B | |
| +1.97% | 39.05B | |
| -14.19% | 26.67B | |
| +1.82% | 24.07B | |
| -24.55% | 18.36B | |
| -4.07% | 11.68B | |
| +21.36% | 11.6B | |
| +8.20% | 11.15B |
MORPHOSYS AG 
